Interested in learning how the battle against Alzheimer's is going (spoiler alert: we are making a ton of progress)? In our upcoming webinar, two experts will discuss the evolving clinical and investment landscape in Alzheimer's disease. This a great chance to hear how VCs and clinicians are thinking about the space. Registration link below. #alzheimersdisease
inThought Research, in collaboration with Spire Bioadvisors, is excited to announce its 3rd virtual fireside chat series on December 13, 2023 at 1:00PM EST. The Future of Alzheimer’s Disease Treatments chat will feature a leading investigator and a #venturecapital associate, Dr. Anton Porsteinsson and Dr. Georgia Frost, respectively, and inThought/Spire experts on #Alzheimer’s Jiah Pearson-Leary and Ben Weintraub. Following our last webinar on GLP-1s, the upcoming webinar will discuss the evolving Alzheimer’s disease landscape following the approval of #Eisai’s #Leqembi and potential approval of #Lilly’s #donanemab. The panel will discuss new therapies, emerging therapies, evolving investment trends, and the broader impact of #anti-amyloid therapies on patient care and accessibility. Register to attend the Zoom fireside chat and get your questions answered by the panel https://lnkd.in/gYfUYPQQ
Associate Healthcare and Life Sciences @ Michael Page
11moRegistered! Excited to tune in. Thanks for sharing!!